PubMed

Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: Results of a pharmacokinetic study.

Kitzen JJ, Puozzo C, de Jonge MJ, Brandely M, Verweij J.

Eur J Cancer. 2009 Nov 25. [Epub ahead of print]PMID: 19944596 [PubMed - as supplied by publisher]Related articles

Interobserver agreement between on-call radiology residents and radiology specialists in the diagnosis of pulmonary embolism using computed tomography pulmonary angiography.

Verweij JW, Hofstee HM, Golding RP, van Waesberghe JH, Smulders YM.

J Comput Assist Tomogr. 2009 Nov-Dec;33(6):952-5.PMID: 19940666 [PubMed - in process]Related articles

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).

Sleijfer S, Ouali M, van Glabbeke M, Krarup-Hansen A, Rodenhuis S, Le Cesne A, Hogendoorn PC, Verweij J, Blay JY.

Eur J Cancer. 2009 Oct 21. [Epub ahead of print]PMID: 19853437 [PubMed - as supplied by publisher]Related articles

Human Plasmodium knowlesi infection detected by rapid diagnostic tests for malaria.

van Hellemond JJ, Rutten M, Koelewijn R, Zeeman AM, Verweij JJ, Wismans PJ, Kocken CH, van Genderen PJ.

Emerg Infect Dis. 2009 Sep;15(9):1478-80.PMID: 19788819 [PubMed - in process]Related articlesFree article

Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer.

Jager A, Verweij J, Sleijfer S.

Nat Rev Clin Oncol. 2009 Oct;6(10):563-5. No abstract available. PMID: 19786999 [PubMed - in process]Related articles

Phase I pharmacokinetic and pharmacodynamic study of the aurora kinase inhibitor danusertib in patients with advanced or metastatic solid tumors.

Steeghs N, Eskens FA, Gelderblom H, Verweij J, Nortier JW, Ouwerkerk J, van Noort C, Mariani M, Spinelli R, Carpinelli P, Laffranchi B, de Jonge MJ.

J Clin Oncol. 2009 Oct 20;27(30):5094-101. Epub 2009 Sep 21.PMID: 19770380 [PubMed - in process]Related articles

Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure.

Deprimo SE, Huang X, Blackstein ME, Garrett CR, Harmon CS, Schöffski P, Shah MH, Verweij J, Baum CM, Demetri GD.

Clin Cancer Res. 2009 Sep 15;15(18):5869-77. Epub 2009 Sep 8.PMID: 19737953 [PubMed - in process]Related articles

Phase I drug combination trial design: walking the tightrope.

Hamberg P, Verweij J.

J Clin Oncol. 2009 Sep 20;27(27):4441-3. Epub 2009 Aug 24. No abstract available. PMID: 19704054 [PubMed - indexed for MEDLINE]Related articles

Detection of Clonorchis sinensis in stool samples using real-time PCR.

Kim EM, Verweij JJ, Jalili A, van Lieshout L, Choi MH, Bae YM, Lim MK, Hong ST.

Ann Trop Med Parasitol. 2009 Sep;103(6):513-8.PMID: 19695156 [PubMed - in process]Related articles

Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.

Mom CH, Verweij J, Oldenhuis CN, Gietema JA, Fox NL, Miceli R, Eskens FA, Loos WJ, de Vries EG, Sleijfer S.

Clin Cancer Res. 2009 Sep 1;15(17):5584-90. Epub 2009 Aug 18.PMID: 19690193 [PubMed - in process]Related articles

Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.

Eskens FA, Steeghs N, Verweij J, Bloem JL, Christensen O, van Doorn L, Ouwerkerk J, de Jonge MJ, Nortier JW, Kraetzschmar J, Rajagopalan P, Gelderblom H.

J Clin Oncol. 2009 Sep 1;27(25):4169-76. Epub 2009 Jul 27.PMID: 19636022 [PubMed - indexed for MEDLINE]Related articles

Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry.

de Bruijn P, Moghaddam-Helmantel IM, de Jonge MJ, Meyer T, Lam MH, Verweij J, Wiemer EA, Loos WJ.

J Pharm Biomed Anal. 2009 Dec 5;50(5):977-82. Epub 2009 Jul 7.PMID: 19628352 [PubMed - in process]Related articles

Parasitological diagnosis combining an internally controlled real-time PCR assay for the detection of four protozoa in stool samples with a testing algorithm for microscopy.

Bruijnesteijn van Coppenraet LE, Wallinga JA, Ruijs GJ, Bruins MJ, Verweij JJ.

Clin Microbiol Infect. 2009 Sep;15(9):869-74. Epub 2009 Jul 14.PMID: 19624500 [PubMed - indexed for MEDLINE]Related articles

Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial.

Le Cesne A, Van Glabbeke M, Verweij J, Casali PG, Findlay M, Reichardt P, Issels R, Judson I, Schoffski P, Leyvraz S, Bui B, Hogendoorn PC, Sciot R, Blay JY.

J Clin Oncol. 2009 Aug 20;27(24):3969-74. Epub 2009 Jul 20.PMID: 19620483 [PubMed - indexed for MEDLINE]Related articles

Characterization of genotypes of Enterocytozoon bieneusi in immunosuppressed and immunocompetent patient groups.

ten Hove RJ, Van Lieshout L, Beadsworth MB, Perez MA, Spee K, Claas EC, Verweij JJ.

J Eukaryot Microbiol. 2009 Jul-Aug;56(4):388-93.PMID: 19602086 [PubMed - indexed for MEDLINE]Related articles

Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY; ESMO Guidelines Working Group.

Ann Oncol. 2009 May;20 Suppl 4:132-6. No abstract available. PMID: 19454434 [PubMed - in process]Related articles

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.

Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I, Guastalla JP, Bachelot T, Perol D, Chabaud S, Hogendoorn PC, Cassier P, Dufresne A, Blay JY; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Cancer Res. 2009 Jul 1;69(13):5383-91. Epub 2009 Jun 23.PMID: 19549917 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors.

Baird RD, Kitzen J, Clarke PA, Planting A, Reade S, Reid A, Welsh L, López Lázaro L, de las Heras B, Judson IR, Kaye SB, Eskens F, Workman P, deBono JS, Verweij J.

Mol Cancer Ther. 2009 Jun;8(6):1430-7. Epub 2009 Jun 9.PMID: 19509256 [PubMed - indexed for MEDLINE]Related articles

Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors.

Romeo S, Debiec-Rychter M, Van Glabbeke M, Van Paassen H, Comite P, Van Eijk R, Oosting J, Verweij J, Terrier P, Schneider U, Sciot R, Blay JY, Hogendoorn PC; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Clin Cancer Res. 2009 Jun 15;15(12):4191-8. Epub 2009 Jun 9.PMID: 19509155 [PubMed - indexed for MEDLINE]Related articles

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).

Sleijfer S, Ray-Coquard I, Papai Z, Le Cesne A, Scurr M, Schöffski P, Collin F, Pandite L, Marreaud S, De Brauwer A, van Glabbeke M, Verweij J, Blay JY.

J Clin Oncol. 2009 Jul 1;27(19):3126-32. Epub 2009 May 18.PMID: 19451427 [PubMed - indexed for MEDLINE]Related articles

Soft tissue sarcoma trials: one size no longer fits all.

Verweij J.

J Clin Oncol. 2009 Jul 1;27(19):3085-7. Epub 2009 May 18. Review. No abstract available. PMID: 19451424 [PubMed - indexed for MEDLINE]Related articles

The applicability of mTOR inhibition in solid tumors.

Konings IR, Verweij J, Wiemer EA, Sleijfer S.

Curr Cancer Drug Targets. 2009 May;9(3):439-50. Review.PMID: 19442061 [PubMed - indexed for MEDLINE]Related articles

Molecular diagnostics of intestinal parasites in returning travellers.

ten Hove RJ, van Esbroeck M, Vervoort T, van den Ende J, van Lieshout L, Verweij JJ.

Eur J Clin Microbiol Infect Dis. 2009 Sep;28(9):1045-53. Epub 2009 May 5.PMID: 19415354 [PubMed - in process]Related articlesFree article

Aurora kinase inhibitors.

Kitzen JJ, de Jonge MJ, Verweij J.

Crit Rev Oncol Hematol. 2009 Apr 13. [Epub ahead of print]PMID: 19369091 [PubMed - as supplied by publisher]Related articles

Strongyloidiasis--the most neglected of the neglected tropical diseases?

Olsen A, van Lieshout L, Marti H, Polderman T, Polman K, Steinmann P, Stothard R, Thybo S, Verweij JJ, Magnussen P.

Trans R Soc Trop Med Hyg. 2009 Oct;103(10):967-72. Epub 2009 Mar 27.PMID: 19328508 [PubMed - in process]Related articles

Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours.

Kitzen JJ, de Jonge MJ, Lamers CH, Eskens FA, van der Biessen D, van Doorn L, Ter Steeg J, Brandely M, Puozzo Ch, Verweij J.

Eur J Cancer. 2009 Jul;45(10):1764-72. Epub 2009 Feb 27.PMID: 19251409 [PubMed - indexed for MEDLINE]Related articles

Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR.

Verweij JJ, Canales M, Polman K, Ziem J, Brienen EA, Polderman AM, van Lieshout L.

Trans R Soc Trop Med Hyg. 2009 Apr;103(4):342-6. Epub 2009 Feb 4.PMID: 19195671 [PubMed - indexed for MEDLINE]Related articles

The price of success: cost-effectiveness of molecularly targeted agents.

Sleijfer S, Verweij J.

Clin Pharmacol Ther. 2009 Feb;85(2):136-8. Review.PMID: 19151639 [PubMed - indexed for MEDLINE]Related articles

Advances in cancer therapeutics.

Sparreboom A, Verweij J.

Clin Pharmacol Ther. 2009 Feb;85(2):113-7. No abstract available. PMID: 19151631 [PubMed - indexed for MEDLINE]Related articles

Lessons learned from independent central review.

Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.

Eur J Cancer. 2009 Jan;45(2):268-74.PMID: 19101138 [PubMed - indexed for MEDLINE]Related articles

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J.

Eur J Cancer. 2009 Jan;45(2):228-47.PMID: 19097774 [PubMed - indexed for MEDLINE]Related articles

Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.

Konings IR, Engels FK, Sleijfer S, Verweij J, Wiemer EA, Loos WJ.

Cancer Chemother Pharmacol. 2009 Aug;64(3):509-16. Epub 2008 Dec 20.PMID: 19096847 [PubMed - indexed for MEDLINE]Related articlesFree article

Individual patient data analysis to assess modifications to the RECIST criteria.

Bogaerts J, Ford R, Sargent D, Schwartz LH, Rubinstein L, Lacombe D, Eisenhauer E, Verweij J, Therasse P; RECIST Working Party.

Eur J Cancer. 2009 Jan;45(2):248-60. Epub 2008 Dec 16.PMID: 19095437 [PubMed - indexed for MEDLINE]Related articles

Effect of cigarette smoking on imatinib in patients in the soft tissue and bone sarcoma group of the EORTC.

van Erp N, Gelderblom H, van Glabbeke M, Van Oosterom A, Verweij J, Guchelaar HJ, Debiec-Rychter M, Peng B, Blay JY, Judson I.

Clin Cancer Res. 2008 Dec 15;14(24):8308-13.PMID: 19088049 [PubMed - indexed for MEDLINE]Related articles

Cancer clinical trial outcomes: any progress in tumour-size assessment?

Verweij J, Therasse P, Eisenhauer E; RECIST working group.

Eur J Cancer. 2009 Jan;45(2):225-7. Epub 2008 Dec 8.PMID: 19068275 [PubMed - indexed for MEDLINE]Related articles

Novel automated biomarker discovery work flow for urinary peptidomics.

Balog CI, Hensbergen PJ, Derks R, Verweij JJ, van Dam GJ, Vennervald BJ, Deelder AM, Mayboroda OA.

Clin Chem. 2009 Jan;55(1):117-25. Epub 2008 Nov 6.PMID: 18988752 [PubMed - indexed for MEDLINE]Related articles

'No risk, no fun': challenges for the oncology phase I clinical trial time-performance.

Verweij J.

Eur J Cancer. 2008 Nov;44(17):2600-7. Epub 2008 Oct 22.PMID: 18951015 [PubMed - indexed for MEDLINE]Related articles

Application of a circulating-cathodic-antigen (CCA) strip test and real-time PCR, in comparison with microscopy, for the detection of Schistosoma haematobium in urine samples from Ghana.

Obeng BB, Aryeetey YA, de Dood CJ, Amoah AS, Larbi IA, Deelder AM, Yazdanbakhsh M, Hartgers FC, Boakye DA, Verweij JJ, van Dam GJ, van Lieshout L.

Ann Trop Med Parasitol. 2008 Oct;102(7):625-33.PMID: 18817603 [PubMed - indexed for MEDLINE]Related articles

Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.

Schlemmer M, Reichardt P, Verweij J, Hartmann JT, Judson I, Thyss A, Hogendoorn PC, Marreaud S, Van Glabbeke M, Blay JY.

Eur J Cancer. 2008 Nov;44(16):2433-6. Epub 2008 Sep 2.PMID: 18771914 [PubMed - indexed for MEDLINE]Related articles

The relevance of microdialysis for clinical on:cology.

Kitzen JJ, Verweij J, Wiemer EA, Loos WJ.

Curr Clin Pharmacol. 2006 Sep;1(3):255-63. Review.PMID: 18666750 [PubMed - indexed for MEDLINE]Related articles

Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate.

Sciot R, Debiec-Rychter M, Daugaard S, Fisher C, Collin F, van Glabbeke M, Verweij J, Blay JY, Hogendoorn PC; EORTC Soft Tissue and Bone Sarcoma Group; Italian Sarcoma Group; Australasian Trials Group.

Eur J Cancer. 2008 Sep;44(13):1855-60. Epub 2008 Jul 22.PMID: 18653326 [PubMed - indexed for MEDLINE]Related articles

GIST as the model of paradigm shift towards targeted therapy of solid tumors: update and perspective on trial design.

Verweij J, Seynaeve C, Sleijfer S.

Adv Exp Med Biol. 2008;610:144-54. Review. No abstract available. PMID: 18593021 [PubMed - indexed for MEDLINE]Related articles

A multiplex PCR tool for the specific identification of Oesophagostomum spp. from pigs.

Lin RQ, Ai L, Zou FC, Verweij JJ, Jiang Q, Li MW, Song HQ, Zhu XQ.

Parasitol Res. 2008 Sep;103(4):993-7. Epub 2008 Jun 26.PMID: 18581142 [PubMed - indexed for MEDLINE]Related articles

Interaction of Cisplatin with the human organic cation transporter 2.

Filipski KK, Loos WJ, Verweij J, Sparreboom A.

Clin Cancer Res. 2008 Jun 15;14(12):3875-80.PMID: 18559608 [PubMed - indexed for MEDLINE]Related articlesFree article

Other endpoints in screening studies for soft tissue sarcomas.

Verweij J.

Oncologist. 2008;13 Suppl 2:27-31. Review.PMID: 18434636 [PubMed - indexed for MEDLINE]Related articlesFree article

Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.

Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.

Anticancer Drugs. 2008 Jul;19(6):607-12.PMID: 18525320 [PubMed - indexed for MEDLINE]Related articles

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group.

Nielsen OS, Dombernowsky P, Mouridsen H, Daugaard S, Van Glabbeke M, Kirkpatrick A, Verweij J.

Sarcoma. 2000;4(1-2):31-5.PMID: 18521432 [PubMed - in process]Related articlesFree article

Low Dose Methotrexate and Vinblastine, Given Weekly to Patients With Desmoid Tumours, is Associated With Major Toxicity.

van der Hul RL, Seynaeve C, van Geel BN, Verweij J.

Sarcoma. 2003;7(3-4):153-7.PMID: 18521380 [PubMed - in process]Related articlesFree article

Pharmacogenetic pathway analysis of docetaxel elimination.

Baker SD, Verweij J, Cusatis GA, van Schaik RH, Marsh S, Orwick SJ, Franke RM, Hu S, Schuetz EG, Lamba V, Messersmith WA, Wolff AC, Carducci MA, Sparreboom A.

Clin Pharmacol Ther. 2009 Feb;85(2):155-63. Epub 2008 May 28.PMID: 18509327 [PubMed - indexed for MEDLINE]Related articles

Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY; ESMO Guidelines Working Group.

Ann Oncol. 2008 May;19 Suppl 2:ii89-93. No abstract available. PMID: 18456783 [PubMed - indexed for MEDLINE]Related articlesFree article